Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Calhoun Jr FP . The management of glaucoma in nanophthalmos. Trans Am Ophthalmol Soc 1975; 73: 97–122.
Trelstad RL, Silbermann NN, Brockhurst RJ . Nanophthalmic sclera. Ultrastructural, histochemical, and biochemical observations. Arch Ophthalmol 1982; 100 (12): 1935–1938.
Forrester JV, Lee WR, Kerr PR, Dua HS . The uveal effusion syndrome and trans-scleral flow. Eye 1990; 4: 354–365.
Elagouz M, Stanescu-Segall D, Jackson TL . Uveal effusion syndrome. Surv Ophthalmol 2010; 55 (2): 134–145.
Uyama M, Takahashi K, Kozaki J, Tagami N, Takada Y, Ohkuma H et al. Uveal effusion syndrome. Clinical features, surgical treatment, histologic examination of the sclera, and pathophysiology. Ophthalmology 2000; 107 (3): 441–449.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Previously presented at the Scottish Ophthalmological Club autumn meeting 2010.
Rights and permissions
About this article
Cite this article
Schmoll, C., Devlin, H. & Foster, P. Uveal Effusion Syndrome as a complication of cyclodiode therapy in nanophthalmos glaucoma. Eye 25, 963–964 (2011). https://doi.org/10.1038/eye.2011.67
Published:
Issue date:
DOI: https://doi.org/10.1038/eye.2011.67